Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay

Victoria Elizondo, Gordon W. Harkins, Batsirai Mabvakure, Sabine Smidt, Paul Zappile, Christian Marier, View ORCID ProfileMatthew Maurano, Victoria Perez, Natalia Mazza, Carolina Beloso, Silvana Ifran, Mariana Fernandez, Andrea Santini, Veronica Perez, Veronica Estevez, Matilde Nin, Gonzalo Manrique, Leticia Perez, Fabiana Ross, Susana Boschi, Maria Noel Zubillaga, Raquel Balleste, Simon Dellicour, Adriana Heguy, View ORCID ProfileRalf Duerr
doi: https://doi.org/10.1101/2020.10.08.20208546
Victoria Elizondo
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: totiep@gmail.com Adriana.Heguy@nyulangone.org Ralf.Duerr@nyulangone.org
Gordon W. Harkins
2South African Medical Research Council Capacity Development Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellville, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Batsirai Mabvakure
3Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabine Smidt
2South African Medical Research Council Capacity Development Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellville, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Zappile
4Genome Technology Center, Office for Science and Research, NYU Langone Health, New York, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Marier
4Genome Technology Center, Office for Science and Research, NYU Langone Health, New York, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Maurano
5Department of Pathology, NYU Grossman School of Medicine, New York, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew Maurano
Victoria Perez
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
6Departamento de Desarrollo Biotecnológico, Instituto de Higiene, Facultad de Medicina, Udelar, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Mazza
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolina Beloso
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
7Departamento de Biodiversidad y Genética. Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvana Ifran
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariana Fernandez
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Santini
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronica Perez
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronica Estevez
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matilde Nin
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gonzalo Manrique
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leticia Perez
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiana Ross
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susana Boschi
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Noel Zubillaga
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raquel Balleste
1Laboratorio de Biología Molecular, Asociación Española Primera en Salud, Montevideo, Uruguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon Dellicour
8Spatial Epidemiology Lab. (SpELL), Université Libre de Bruxelles, Bruxelles, Belgium
9Department of Microbiology, Immunology and Transplantation, Rega Institute, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriana Heguy
4Genome Technology Center, Office for Science and Research, NYU Langone Health, New York, New York, United States of America
5Department of Pathology, NYU Grossman School of Medicine, New York, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: totiep@gmail.com Adriana.Heguy@nyulangone.org Ralf.Duerr@nyulangone.org
Ralf Duerr
5Department of Pathology, NYU Grossman School of Medicine, New York, New York, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ralf Duerr
  • For correspondence: totiep@gmail.com Adriana.Heguy@nyulangone.org Ralf.Duerr@nyulangone.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

COVID-19 is a respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and declared by the World Health Organization a global public health emergency. Among the severe outbreaks across South America, Uruguay has become known for curtailing SARS-CoV-2 exceptionally well. To understand the SARS-CoV-2 introductions, local transmissions, and associations with genomic and clinical parameters in Uruguay, we sequenced the viral genomes of 44 outpatients and inpatients in a private healthcare system in its capital, Montevideo, from March to May 2020. We performed a phylogeographic analysis using sequences from our cohort and other studies that indicate a minimum of 23 independent introductions into Uruguay, resulting in five major transmission clusters. Our data suggest that most introductions resulting in chains of transmission originate from other South American countries, with the earliest seeding of the virus in late February 2020, weeks before the borders were closed to all non-citizens and a partial lockdown implemented. Genetic analyses suggest a dominance of S and G clades (G, GH, GR) that make up >90% of the viral strains in our study. In our cohort, lethal outcome of SARS-CoV-2 infection significantly correlated with arterial hypertension, kidney failure, and ICU admission (FDR < 0.01), but not with any mutation in a structural or non-structural protein, such as the spike D614G mutation. Our study contributes genetic, phylodynamic, and clinical correlation data about the exceptionally well-curbed SARS-CoV-2 outbreak in Uruguay, which furthers the understanding of disease patterns and regional aspects of the pandemic in Latin America.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

All the work at the Laboratorio de Biologia Molecular AEPS was supported by internal funding from the Asociacion Espanola Primera en Salud. SD is supported by the Fonds National de la Recherche Scientifique (FNRS, Belgium). RD was partially supported by the National Institute of Health (NIH) grant 1R01AI122953. AH, CM, and PZ are supported by the Genome Technology Center, and in part by the Cancer Center Support Grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The molecular lab at the Asociacion Espanola Primera en Salud (AEPS) is a fully accredited clinical lab, regulated by the Uruguayan Ministry of Health (Ministerio de Salud Pubica, MSP). Sampling was done according to the regional IRB guidelines and the recommendations of the MSP. Our study was evaluated by the commission of bioethics and ethics in research of the AEPS, headed by Fernando Garcia [14-16]. IRB approval was waived, because the genetic analysis was restricted to the virus and not the host, and clinical correlation analyses were done on fully de-identified samples (UY IDs and GISAID IDs were given by the Uruguayan and New York research teams, respectively, and are not traceable to any medical record number). The participants provided informed oral consent, and the data were analyzed anonymously. For participants <18 years of age, formal written or verbal consent was obtained from the parent/guardian at sampling, and data were kept anonymously for the entire study. The molecular clinical lab at AEPS is accredited for diagnostic RT-PCR tests for SARS-CoV-2 (COVID-19) in Uruguay.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵# Shared first authors

  • Supplemental Methods added

Data Availability

All data referred to in the manuscript are fully available without restriction, and a summary is provided in Table S1 of the manuscript. All SARS-CoV-2 sequences are available from the GISAID database (accession numbers listed in Table S1).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay
Victoria Elizondo, Gordon W. Harkins, Batsirai Mabvakure, Sabine Smidt, Paul Zappile, Christian Marier, Matthew Maurano, Victoria Perez, Natalia Mazza, Carolina Beloso, Silvana Ifran, Mariana Fernandez, Andrea Santini, Veronica Perez, Veronica Estevez, Matilde Nin, Gonzalo Manrique, Leticia Perez, Fabiana Ross, Susana Boschi, Maria Noel Zubillaga, Raquel Balleste, Simon Dellicour, Adriana Heguy, Ralf Duerr
medRxiv 2020.10.08.20208546; doi: https://doi.org/10.1101/2020.10.08.20208546
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay
Victoria Elizondo, Gordon W. Harkins, Batsirai Mabvakure, Sabine Smidt, Paul Zappile, Christian Marier, Matthew Maurano, Victoria Perez, Natalia Mazza, Carolina Beloso, Silvana Ifran, Mariana Fernandez, Andrea Santini, Veronica Perez, Veronica Estevez, Matilde Nin, Gonzalo Manrique, Leticia Perez, Fabiana Ross, Susana Boschi, Maria Noel Zubillaga, Raquel Balleste, Simon Dellicour, Adriana Heguy, Ralf Duerr
medRxiv 2020.10.08.20208546; doi: https://doi.org/10.1101/2020.10.08.20208546

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5275)
  • Forensic Medicine (3)
  • Gastroenterology (197)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5904)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (769)
  • Nursing (43)
  • Nutrition (132)
  • Obstetrics and Gynecology (144)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2028)
  • Radiology and Imaging (350)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)